KennethRMurrayMD

Sleep Medicine

Assistant Clinical Professor of Neurology, SUNY Buffalo

Are you Dr. Murray?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 72 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Dr. Kenneth Murray, MD is a board certified neurologist in Cullman, Alabama. He is currently licensed to practice medicine in Alabama, Nebraska, and Texas. He is affiliated with Cullman Regional Medical Center and is an Assistant Clinical Professor of Neurology at SUNY Buffalo.

University at BuffaloResidency, Neurology, 1983 - 1987
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 1983

Buffalo Spree Magazine Castle Connolly, 2011-2014
CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013

PubMed

Late cortical disinhibition in human motor cortex: a triple-pulse transcranial magnetic stimulation study.
Cash RFH, Ziemann U, Murray K, Thickbroom GW> ;J. Neurophysiol.. 2010-01-01
A rapidly progressive neuropathy.
Murray K, Davenport RJ> ;Pract Neurol. 2009-06-01
Sporadic Creutzfeldt-Jakob disease in two adolescents.
Murray K, Ritchie DL, Bruce M, Young CA, Doran M, Ironside JW, Will RG> ;J. Neurol. Neurosurg. Psychiatr.. 2008-01-01
Serotonin facilitates a persistent calcium current in motoneurons of rats with and without chronic spinal cord injury.
Li X, Murray K, Harvey PJ, Ballou EW, Bennett DJ> ;J. Neurophysiol.. 2007-02-01
Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease.
Collins SJ, Sanchez-Juan P, Masters CL, Klug GM, van Duijn C, Poleggi A, Pocchiari M, Almonti S, Cuadrado-Corrales N, de Pedro-Cuesta J, Budka H, Gelpi E, Glatzel M, T...> ;Brain. 2006-09-01
Growth and fate of PSA-NCAM+ precursors of the postnatal brain.
Ben-Hur T, Rogister B, Murray K, Rougon G, Dubois-Dalcq M> ;J. Neurosci.. 1998-08-01
Seizures and the regulation of neurotrophic factor and neuropeptide gene expression in brain.
Gall C, Lauterborn J, Bundman M, Murray K, Isackson P> ;Epilepsy Res. Suppl.. 1991-01-01
Join now to see all

Sage Therapeutics and Biogen Present Further Analyses from Phase 3 SKYLARK Study of Zuranolone in Postpartum Depression at the European College of Neuropsychopharmacology (ECNP) CongressOctober 17th, 2022
Sage Therapeutics and Biogen Announce That the Phase 3 SKYLARK Study of Zuranolone in Postpartum Depression Met Its Primary and All Key Secondary EndpointsJune 1st, 2022
How Doctors DieDecember 13th, 2018